XFM and HERFD-XAS studies of selenium in tissues and whole blood from mice supplemented with potentially therapeutic selenocompounds
These results support the hypothesised <i>in vivo</i> reduction of SeN and subsequent bioaccumulation in the blood and various tissues. The present findings highlight marked differences in the bioavailability and utilisation of these purported therapeutic selenocompounds.
Authors
- Linda Vogt (ORCID: https://orcid.org/0000-0002-0835-0457)
- Paul K. Witting (ORCID: https://orcid.org/0000-0003-2237-7004)
- Kangzhe Xie
- Graham N. George (ORCID: https://orcid.org/0000-0002-0420-7493)
- Dimosthenis Sokaras (ORCID: https://orcid.org/0000-0001-8117-1933)
- Hugh H. Harris (ORCID: https://orcid.org/0000-0002-3472-8628)
- Jonathan C. Morris (ORCID: https://orcid.org/0000-0002-5109-9069)
- Tamara Ortíz (ORCID: https://orcid.org/0000-0002-6321-9371)
- Iliya Dragutinovic (ORCID: https://orcid.org/0009-0001-4689-5976)
- Jordan Hunter
- Ani T. Baker
- Daryl L. Howard
Institutions
- The University of Sydney (AU)
- Australian Nuclear Science and Technology Organisation (AU)
- SLAC National Accelerator Laboratory (US)
- Australian Synchrotron (AU)
- UNSW Sydney (AU)
- University of Saskatchewan (CA)
- Kensington Health (CA)
- The University of Adelaide (AU)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Redox Report
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1080/13510002.2026.2626151
- Primary Topic
- Selenium in Biological Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00